GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Accounts Payable & Accrued Expense

NKY Medical Holdings (SZSE:300109) Accounts Payable & Accrued Expense : ¥332 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings Accounts Payable & Accrued Expense?

NKY Medical Holdings's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥389 Mil) to Dec. 2023 (¥374 Mil) and declined from Dec. 2023 (¥374 Mil) to Mar. 2024 (¥332 Mil).

NKY Medical Holdings's annual accounts payable & accrued expense increased from Dec. 2021 (¥414 Mil) to Dec. 2022 (¥448 Mil) but then declined from Dec. 2022 (¥448 Mil) to Dec. 2023 (¥374 Mil).

NKY Medical Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for NKY Medical Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings Accounts Payable & Accrued Expense Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 153.34 247.32 414.45 448.19 373.55

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 414.85 358.06 389.02 373.55 331.72

NKY Medical Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

NKY Medical Holdings (SZSE:300109) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
SZSE:000411 SHSE:688176 SHSE:600666 SHSE:600713 SZSE:301507 SZSE:301096 SZSE:300006 SZSE:301281 SHSE:600613 SZSE:002198 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
Website
http://www.boai-nky.com
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines